Insight Molecular Diagnostics Inc
NASDAQ:IMDX

Watchlist Manager
Insight Molecular Diagnostics Inc Logo
Insight Molecular Diagnostics Inc
NASDAQ:IMDX
Watchlist
Price: 5.09 USD -1.17% Market Closed
Market Cap: 145.9m USD

Wall Street
Price Targets

IMDX Price Targets Summary
Insight Molecular Diagnostics Inc

Wall Street analysts forecast IMDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMDX is 7.14 USD with a low forecast of 4.04 USD and a high forecast of 9.45 USD.

Lowest
Price Target
4.04 USD
21% Downside
Average
Price Target
7.14 USD
40% Upside
Highest
Price Target
9.45 USD
86% Upside
Insight Molecular Diagnostics Inc Competitors:
Price Targets
1530
3SBio Inc
39% Upside
NBIX
Neurocrine Biosciences Inc
15% Upside
2126
JW (Cayman) Therapeutics Co Ltd
105% Upside
CVAC
CureVac NV
7% Downside
AMRN
Amarin Corporation PLC
14% Downside
2616
CStone Pharmaceuticals
142% Upside
LCTX
Lineage Cell Therapeutics Inc
137% Upside
TECX
AVROBIO Inc
304% Upside

Revenue
Forecast

Revenue Estimate
Insight Molecular Diagnostics Inc

The compound annual growth rate of Insight Molecular Diagnostics Inc's revenue for the next 3 years is 79%.

N/A
Past Growth
79%
Estimated Growth
Estimates Accuracy
-21%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Insight Molecular Diagnostics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Insight Molecular Diagnostics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-90%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMDX's stock price target?
Price Target
7.14 USD

According to Wall Street analysts, the average 1-year price target for IMDX is 7.14 USD with a low forecast of 4.04 USD and a high forecast of 9.45 USD.

What is Insight Molecular Diagnostics Inc's Revenue forecast?
Projected CAGR
79%

The compound annual growth rate of Insight Molecular Diagnostics Inc's revenue for the next 3 years is 79%.

Back to Top